Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
News
Sports
TV & Film
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/3d/4f/ca/3d4fcae5-9849-74ae-12af-20e79bbb83bd/mza_6559795125475649946.jpg/600x600bb.jpg
RheumMadness Rheumatology Podcast
RheumMadness
47 episodes
4 months ago
In this episode, we recap the final results of RheumMadness 2025 and say thank you to our may contributors. If you haven't already, complete our RheumMadness 2025 post-survey here: https://duke.qualtrics.com/jfe/form/SV_1H1cHULbm0R1XWS To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/r...
Show more...
Courses
Education
RSS
All content for RheumMadness Rheumatology Podcast is the property of RheumMadness and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode, we recap the final results of RheumMadness 2025 and say thank you to our may contributors. If you haven't already, complete our RheumMadness 2025 post-survey here: https://duke.qualtrics.com/jfe/form/SV_1H1cHULbm0R1XWS To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/r...
Show more...
Courses
Education
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/3d/4f/ca/3d4fcae5-9849-74ae-12af-20e79bbb83bd/mza_6559795125475649946.jpg/600x600bb.jpg
5.4 Cytokine Crushers
RheumMadness Rheumatology Podcast
36 minutes
10 months ago
5.4 Cytokine Crushers
In this episode, we are joined by Michael Macklin, MD, PharmD, Assistant Professor of Medicine at the University of Chicago, to discuss the teams in the Cytokine Crushers region of RheumMadness 2025, the Innovation Invitational.This is part 1 of the conversation, where we go in depth about the long-term outcomes of anifrolumab in SLE study and give a primer about type 1/2 cytokines so you're ready to dig into the TYK2 in SLE and Oral Anti-IL23 studies.Join us again next week for part 2 of thi...
RheumMadness Rheumatology Podcast
In this episode, we recap the final results of RheumMadness 2025 and say thank you to our may contributors. If you haven't already, complete our RheumMadness 2025 post-survey here: https://duke.qualtrics.com/jfe/form/SV_1H1cHULbm0R1XWS To learn more about RheumMadness: https://sites.duke.edu/rheummadness/ Subscribe to our newsletter: https://lists.duke.edu/sympa/subscribe/rheummadness Find us on social media: Bluesky: @rheummadness.bsky.social Instagram: https://www.instagram.com/r...